ClinConnect ClinConnect Logo
Search / Trial NCT05686473

Psychoeducation of Parents to Children With FASD

Launched by SORLANDET HOSPITAL HF · Jan 5, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Fasd Psychoeducation Parenting Information Program

ClinConnect Summary

This clinical trial is looking at how a special program can help parents of children with Fetal Alcohol Spectrum Disorders (FASD). FASD can cause challenges in learning and behavior because of brain damage that happens before birth due to alcohol exposure. The goal of this study is to teach parents ways to better understand their children’s needs and help improve their behavior and self-control. By participating in this program, parents will learn useful strategies based on proven methods used around the world.

To be eligible for this trial, children and teenagers aged 2.5 to 18 years who have been exposed to alcohol before birth can participate. The study targets those who have a confirmed history of alcohol exposure during pregnancy, but children who have been adopted and show signs of FASD can also join. However, children with certain conditions, like genetic syndromes or serious vision or hearing problems, will not be included. This program is not yet recruiting participants, but it aims to provide valuable support to families dealing with the effects of FASD.

Gender

ALL

Eligibility criteria

  • All children and adolescents (age 2,5-18 years) referred to the Regional Competence Centre for children with prenatal alcohol exposure in Arendal, Norway will be invited to participate in the current research project.
  • Inclusion criteria:
  • Valid information about alcohol exposure in fetal life. Exceptions to this inclusion criterion are children who have been adopted and with dysmorphic features that are consistent with full Fetal Alcohol Syndrome.
  • Exclusion Criteria:
  • Children with known genetic syndromes, progressive brain and neuromuscular diseases or major sensory defects (blindness or deafness).

About Sorlandet Hospital Hf

Sørlandet Hospital HF is a leading healthcare institution in Norway dedicated to providing high-quality medical services and advancing clinical research. As a prominent sponsor of clinical trials, the hospital focuses on innovative healthcare solutions that enhance patient outcomes and contribute to the medical knowledge base. With a commitment to ethical standards and regulatory compliance, Sørlandet Hospital HF collaborates with a diverse range of partners to conduct rigorous studies across various therapeutic areas, ensuring that research findings are both scientifically robust and clinically relevant. The institution's multidisciplinary approach fosters an environment of excellence in patient care and research, positioning it as a key player in the Norwegian healthcare landscape.

Locations

Arendal, , Norway

Patients applied

0 patients applied

Trial Officials

Jon S Skranes, Dr Med

Principal Investigator

Sørlandet Hospital HF

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials